Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea.

Published in: PharmacoEconomics - open (2022)

This study describes an alternative method for conducting incidence-based COI studies using cross-sectional claims data.

Keyphrases